| Testing for drug hypersensitivity syndromes CM Rive, J Bourke, EJ Phillips The Clinical Biochemist Reviews 34 (1), 15, 2013 | 123 | 2013 |
| HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity NM Keane, RK Pavlos, E McKinnon, A Lucas, C Rive, CC Blyth, D Dunn, ... Aids 28 (13), 1891-1901, 2014 | 70 | 2014 |
| Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles R Pavlos, EJ McKinnon, DA Ostrov, B Peters, S Buus, D Koelle, A Chopra, ... Scientific reports 7 (1), 8653, 2017 | 53 | 2017 |
| Rapid selection and identification of functional CD8+ T cell epitopes from large peptide-coding libraries G Sharma, CM Rive, RA Holt Nature Communications 10 (1), 4553, 2019 | 50 | 2019 |
| Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury LM Williamson, CM Rive, D Di Francesco, E Titmuss, HJE Chun, ... NPJ Precision Oncology 5 (1), 103, 2021 | 28 | 2021 |
| Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma S Sneddon, CM Rive, S Ma, IM Dick, RJN Allcock, SD Brown, RA Holt, ... OncoImmunology 9 (1), 1684713, 2020 | 18 | 2020 |
| Complementary Methods for de Novo Monoclonal Antibody Sequencing to Achieve Complete Sequence Coverage J Cheng, L Wang, CM Rive, RA Holt, GB Morin, DDY Chen Journal of proteome research 19 (7), 2700-2707, 2020 | 17 | 2020 |
| Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus CM Rive, E Yung, L Dreolini, SD Brown, CG May, DJ Woodsworth, ... Molecular Therapy-Methods & Clinical Development 26, 4-14, 2022 | 10 | 2022 |
| Recombinant T cell receptors specific for HLA-A* 02: 01-restricted neoepitopes containing KRAS codon 12 hotspot mutations CM Rive, E Yung, CS Hughes, SD Brown, G Sharma, L Dreolini, ... bioRxiv, 2020.06. 15.149021, 2020 | 4 | 2020 |
| 7th drug hypersensitivity meeting: part one DF Carr, WH Chung, RE Jenkiins, M Chaponda, G Nwikue, ... Clinical and Translational Allergy 6 (S3), 31, 2016 | 4 | 2016 |
| Specific Binding Characteristics of HLA Alleles Associate with Nevirapine Hypersensitivity EJP Rebecca Pavlos, Craig Rive, Elizabeth McKinnon, David Ostrov, Pablo C ... Conference on Retroviruses and Opportunistic Infections (CROI), At Boston …, 2014 | 4* | 2014 |
| HLA class I-drug-T-cell receptor interactions in SJS/TEN C Rive, R Pavlos, D Ostrov, P Plasencia, SI Hung, WH Chung, B Peters, ... Clinical and Translational Allergy 4 (3), P2, 2014 | 2 | 2014 |
| Response to nivolumab in a pediatric chordoma with overexpression of brachyury L Williamson, C Rive, DD Francesco, E Titmuss, E Chun, S Brown, ... Cancer Research 81 (13_Supplement), 630-630, 2021 | 1 | 2021 |
| Selective B cell depletion upon infusion of replication-incompetent anti-CD19 CAR lentivirus CM Rive, E Yung, L Dreolini, DJ Woodsworth, RA Holt bioRxiv, 2020.05. 15.098335, 2020 | 1 | 2020 |
| Augmenting and broadening T cell responses against mutated tumour neo-antigens BW Robinson, S Ma, J Chee, C Rive, PV Miert, RA Holt, J Creaney Cancer Research 77 (13_Supplement), 608-608, 2017 | | 2017 |
| The immunopathogenesis of drug hypersensitivity C Rive Murdoch University, 2016 | | 2016 |
| 6th Drug Hypersensitivity Meeting (DHM 6) L Valeyrie-Allanore, M Mockenhaupt, P Sekula, F Berrehar, N Ortonne, ... Clinical and translational allergy 4 (Suppl 3), O1-P149, 2014 | | 2014 |
| Development of a low bias target enrichment method to estimate viral variation using 454 sequencing C Rive, M Watson, A Chopra, D Cooper, E Demaine, S Mallal 21st Annual Combined Biological Sciences Meeting, 2011 | | 2011 |
